Marshall Islands vs New Zealand: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Marshall Islands
62.0%
in 2024
New Zealand
60.0%
in 2024
Marshall Islands rank
131st
New Zealand rank
133rd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Marshall Islands
- New Zealand
How they compare
Marshall Islands currently reports 62.0% against 60.0% in New Zealand, a difference of 2.0%.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was New Zealand ahead.
Marshall Islands ranks 131st and New Zealand ranks 133rd of 146 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 87.0% | 38.0% | New Zealand |
| 2010s | 51.4% | 92.6% | 41.2% | New Zealand |
| 2020s | 50.4% | 81.2% | 30.8% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Marshall Islands or New Zealand?
- Marshall Islands, at 62.0% against 60.0% in New Zealand as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Marshall Islands and New Zealand?
- 2.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and New Zealand?
- 16 years are reported by both, from 2009 to 2024.
- How do Marshall Islands and New Zealand rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Marshall Islands ranks 131st and New Zealand ranks 133rd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.